ASX-LISTED New Zealand-based biotech company Zoono Group has signed an agreement with German pharmaceutical and healthcare company Midas Pharma GmbH for sales and distribution in the EU and selected global markets.
The agreement is the culmination of six months' work on behalf of both parties, the company said.
Zoono manufactures a range of "scientifically-validated and environmentally friendly" antimicrobial sprays, wipes & foams.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Mar 19
